James Sapirstein
Chief Executive Officer bei FIRST WAVE BIOPHARMA, INC.
Vermögen: 162 581 $ am 31.03.2024
Profil
James E. Sapirstein ist Chairman & Chief Executive Officer bei AzurRx BioPharma, Inc. und Chairman & Chief Executive Officer bei Marizyme, Inc. sowie unabhängiger Director bei Enochian Biosciences, Inc. und Director & Member-Emerging Companies bei Biotechnology Innovation Organization sowie unabhängiger Director bei Blue Water Acquisition Corp. Er ist Mitglied des Board of Directors bei Enochian Biosciences, Inc. und Leading Biosciences, Inc. sowie bei Biotechnology Innovation Organization, BioNJ, Inc. und Clinical Supplies Management, Inc. und Blue Water Acquisition Corp. Herr Sapirstein war zuvor als unabhängiger Direktor bei NanoViricides, Inc. beschäftigt, als unabhängiger Direktor bei Panther Biotechnology, Inc., als unabhängiger Direktor bei RespireRx Pharmaceuticals, Inc., als Chief Executive Officer & Direktor bei ContraVir Pharmaceuticals, Inc., als Chief Executive Officer & Direktor bei Alliqua, Inc., als Präsident, Chief Executive Officer & Direktor bei Tobira Therapeutics, Inc. /Old/, Executive Vice President-Metabolic & Endocrinology bei Serono, Inc., Global Marketing Lead bei Gilead Sciences, Inc., Director-International Marketing bei Bristol Myers Squibb Co., Principal bei Eli Lilly & Co. und Product Director bei Hoffmann-La Roche, Inc. Er erhielt seinen Bachelor-Abschluss von der Rutgers State University of New Jersey und einen MBA von der Fairleigh Dickinson University.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
01.04.2024 | 37 105 ( 1,83% ) | 162 520 $ | 31.03.2024 | |
16.10.2023 | 14 ( inf% ) | 61 $ | 31.03.2024 | |
ONCONETIX INC
-.--% | 05.04.2024 | 0 ( -.--% ) | - $ | 31.03.2024 |
RENOVARO INC.
-.--% | 06.03.2024 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von James Sapirstein
Unternehmen | Position | Beginn |
---|---|---|
RENOVARO INC. | Director/Board Member | 06.03.2018 |
FIRST WAVE BIOPHARMA, INC. | Chief Executive Officer | 08.10.2019 |
ZYVERSA THERAPEUTICS, INC. | Director/Board Member | 05.01.2023 |
ONCONETIX, INC. | Chairman | - |
Clinical Supplies Management, Inc.
Clinical Supplies Management, Inc. Medical/Nursing ServicesHealth Services Clinical Supplies Management, Inc. engages in the provision of clinical trial supply solutions for pharmaceutical and biotechnology companies. Its clinical services include packaging and labeling; storage and global distribution; chain management consulting; and returns, reconciliation, and destruction. The company was founded by Gerald E. Finken in 1997 and is headquartered in Fargo, ND. | Director/Board Member | - |
Blue Water Acquisition Corp. II
Blue Water Acquisition Corp. II Financial ConglomeratesFinance Blue Water Acquisition Corp. II is a blank check company. It is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded by Joseph Hernandez and is headquartered in Greenwich, CT. | Director/Board Member | - |
Leading Biosciences, Inc.
Leading Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Leading Biosciences, Inc. provides healthcare services. It offers therapy for severe sepsis, septic shock, and multi-organ failure. The company was founded by John Rodenrys and is headquartered in Carlsbad, CA. | Director/Board Member | 01.03.2016 |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Director/Board Member | 16.06.2015 |
Ehemalige bekannte Positionen von James Sapirstein
Unternehmen | Position | Ende |
---|---|---|
MARIZYME, INC. | Chief Executive Officer | 24.06.2021 |
░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░ ░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Ausbildung von James Sapirstein
Rutgers State University of New Jersey | Undergraduate Degree |
Fairleigh Dickinson University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 12 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
GILEAD SCIENCES, INC. | Health Technology |
ELI LILLY AND COMPANY | Health Technology |
RESPIRERX PHARMACEUTICALS INC. | Health Technology |
RENOVARO INC. | Health Technology |
PROBILITY MEDIA CORPORATION | Commercial Services |
HEPION PHARMACEUTICALS, INC. | Health Technology |
NANOVIRICIDES, INC. | Health Technology |
MARIZYME, INC. | Health Technology |
FIRST WAVE BIOPHARMA, INC. | Health Technology |
ZYVERSA THERAPEUTICS, INC. | Finance |
ONCONETIX, INC. | Health Technology |
Private Unternehmen | 12 |
---|---|
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
Tobira Therapeutics, Inc. /Old/
Tobira Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which focuses on developing and commercializing of therapies to treat liver disease, HIV, fibrosis and inflammation. Its lead product candidate, cenicriviroc or CVC, is a proprietary immunomodulator that may be used to treat a number of diseases, including NASH, kidney fibrosis, HIV-1 and others. The company was founded by Eckard Weber in September 2006 and is headquartered in South San Francisco, CA. | Health Technology |
BioNJ, Inc.
BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Commercial Services |
Clinical Supplies Management, Inc.
Clinical Supplies Management, Inc. Medical/Nursing ServicesHealth Services Clinical Supplies Management, Inc. engages in the provision of clinical trial supply solutions for pharmaceutical and biotechnology companies. Its clinical services include packaging and labeling; storage and global distribution; chain management consulting; and returns, reconciliation, and destruction. The company was founded by Gerald E. Finken in 1997 and is headquartered in Fargo, ND. | Health Services |
Tobira Therapeutics, Inc.
Tobira Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The company was founded on October 6, 2006 and is headquartered in Madison, NJ. | Health Technology |
Leading Biosciences, Inc.
Leading Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Leading Biosciences, Inc. provides healthcare services. It offers therapy for severe sepsis, septic shock, and multi-organ failure. The company was founded by John Rodenrys and is headquartered in Carlsbad, CA. | Commercial Services |
Blue Water Biotech, Inc.
Blue Water Biotech, Inc. Pharmaceuticals: MajorHealth Technology Blue Water Biotech, Inc. is a biotechnology company, which engages in the research and development of transformational vaccines to prevent infectious diseases worldwide. Its platform includes the BWV Norovirus (NoV) S&P Nanoparticle Versatile Vaccine. Bioengineering the shell (S) and protruding (P) domains of the norovirus capsid protein, polyvalent nanoparticles and polymers/oligomers provide a versatile vaccine platform with wide applications. The company was founded by Joseph Hernandez on October 26, 2018 and is headquartered in Cincinnati, OH. | Health Technology |
Blue Water Acquisition Corp.
Blue Water Acquisition Corp. Financial ConglomeratesFinance Blue Water Acquisition Corp. operates as a blank check company. It is incorporated for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded by Joseph Hernandez on May 22, 2020 and is headquartered in Greenwich, CT. | Finance |
Blue Water Acquisition Corp. II
Blue Water Acquisition Corp. II Financial ConglomeratesFinance Blue Water Acquisition Corp. II is a blank check company. It is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded by Joseph Hernandez and is headquartered in Greenwich, CT. | Finance |
Alliqua BioMedical, Inc.
Alliqua BioMedical, Inc. BiotechnologyHealth Technology Alliqua BioMedical, Inc. engages in commercializing differentiated regenerative medical products which assist the body in the repair or replacement of soft tissue. Its commercial wound care portfolio consists of wound bed preparation and human biologics. It also manufactures custom electron beam cross-linked and aqueous polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was founded on October 27, 1997 and is headquartered in Langhorne, PA. | Health Technology |